Hope For Those Going Up in Smoke: Cannabis Industry Eyes Bankruptcy Reform Amid Legal Limbo

Distressed U.S. cannabis operators, historically barred from bankruptcy relief due to federal legal constraints, may soon find a glimmer of hope. As attitudes shift and federal marijuana rescheduling looms, the landscape for financial restructuring in the cannabis industry could change significantly.

Legal Paradoxes

Ryan Spengler, an associate specializing in financial restructuring law at Duane Morris, expressed cautious optimism to MJBizDaily. He highlighted that evolving court stances, coupled with potential federal rescheduling of cannabis, might pave the way for new bankruptcy avenues. “If there's a movement from these bankruptcy courts before rescheduling even happens, if rescheduling were to happen, you would expect more courts to take similar stances – if not more drastic stances – toward favoring cannabis-related companies in bankruptcy,” Spengler noted.

Emerging Alternatives And Seeds Of Judicial Change

Cannabis companies often turn to alternatives like state court receiverships or out-of-court restructuring. Some even explore Canadian insolvency laws. This complexity stems from the federal U.S. Bankruptcy Code, which prohibits plans involving activities forbidden by federal law. Since cannabis remains illegal under the federal Controlled Substances Act, traditional bankruptcy routes are closed to state-regulated marijuana businesses.

However, recent court decisions suggest a shifting landscape. For example, the U.S. Bankruptcy Court for the Central District of California, in a 2023 case titled "In re The Hacienda Co.", approved a plan that involved selling shares in a Canadian cannabis firm, circumventing federal legal barriers. This marked a significant departure from previous stricter stances.

The Economic Impact Of Rescheduling Cannabis

These shifts are mirrored by potential legal reforms. The U.S. Drug Enforcement Administration is contemplating moving cannabis to Schedule 3 of the Controlled Substances Act, a move that, while not eliminating all obstacles, could soften the financial impact on cannabis companies by eliminating certain tax burdens under section 280E.

Developing News: MedMen's Bankruptcy

The bankruptcy scenario for the sector is further complicated by high-profile cases like MedMen Enterprises Inc., once dubbed the “Apple Store of weed.” MedMen’s declaration of bankruptcy highlights the pressing financial perils even well-funded cannabis ventures face. “The difficult decision to shut down operations and commence the Bankruptcy Proceedings and Receivership Proceedings was made after careful consideration of the current financial condition of the Company and its subsidiaries, their inability to pay their liabilities as they become due and the anticipated enforcement actions of secured creditors,” MedMen announced in press release on Friday. 

While a full solution may still be years away, the evolving judicial attitudes and the anticipated rescheduling of cannabis point towards a more flexible and supportive approach to cannabis-related financial distress.

Keep your own cannabis business on track and raise capital at Benzinga's New Jersey Market Spotlight on June 17. Network with key industry players, hear from the top operators and close deals that will shape the future. Act now— spots are filling fast. Get your tickets here.